-
公开(公告)号:US20060063784A1
公开(公告)日:2006-03-23
申请号:US11221846
申请日:2005-09-09
申请人: Yanong Wang , Ariamala Gopalsamy , Erick Honores , Lee Jennings , Steven Johnson , Dennis Powell , Fuk-Wah Sum , Hwei-Ru Tsou , Biqi Wu , Nan Zhang
发明人: Yanong Wang , Ariamala Gopalsamy , Erick Honores , Lee Jennings , Steven Johnson , Dennis Powell , Fuk-Wah Sum , Hwei-Ru Tsou , Biqi Wu , Nan Zhang
IPC分类号: A61K31/519 , C07D487/04
CPC分类号: C07D487/04 , A61K31/519
摘要: This invention relates to novel methods of use of certain pyrazolo[1,5-a]pyrimidine compounds and the therapeutically acceptable salts thereof. This invention also relates to novel methods of using these compounds as anti-proliferative agents in mammals, including humans.
摘要翻译: 本发明涉及使用某些吡唑并[1,5-a]嘧啶化合物及其治疗上可接受的盐的新方法。 本发明还涉及在哺乳动物(包括人)中使用这些化合物作为抗增殖剂的新方法。
-
2.Substituted pyrazolo[1,5-a] pyrimidines and process for making same 审中-公开
标题翻译: 取代的吡唑并[1,5-a]嘧啶及其制备方法公开(公告)号:US20060063785A1
公开(公告)日:2006-03-23
申请号:US11221847
申请日:2005-09-09
申请人: Yanong Wang , Ariamala Gopalsamy , Dennis Powell , Hwei-Ru Tsou , Nan Zhang
发明人: Yanong Wang , Ariamala Gopalsamy , Dennis Powell , Hwei-Ru Tsou , Nan Zhang
IPC分类号: A61K31/519 , C07D487/04
CPC分类号: C07D487/04
摘要: This invention relates to novel pyrazolo[1,5-a]pyrimidine compounds and the therapeutically acceptable salts thereof. These compounds are useful as anti-proliferative agents in mammals, including humans.
摘要翻译: 本发明涉及新的吡唑并[1,5-a]嘧啶化合物及其治疗上可接受的盐。 这些化合物可用作哺乳动物(包括人)中的抗增殖剂。
-
3.3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors 失效
标题翻译: 3-氰基喹啉,3-氰基-1,6-萘啶和3-氰基-1,7-萘啶作为蛋白激酶抑制剂公开(公告)号:US06689772B1
公开(公告)日:2004-02-10
申请号:US10318213
申请日:2002-12-12
申请人: Diane Harris Boschelli , Yanong Wang , Frank Charles Boschelli , Dan Maarten Berger , Nan Zhang , Dennis William Powell , Fei Ye , Ayako Yamashita , Frenel Fils DeMorin , Biqi Wu , Hwei-Ru Tsou , Elsebe Geraldine Overbeek-Klumpers , Allan Wissner
发明人: Diane Harris Boschelli , Yanong Wang , Frank Charles Boschelli , Dan Maarten Berger , Nan Zhang , Dennis William Powell , Fei Ye , Ayako Yamashita , Frenel Fils DeMorin , Biqi Wu , Hwei-Ru Tsou , Elsebe Geraldine Overbeek-Klumpers , Allan Wissner
IPC分类号: A61K3133
CPC分类号: C07D401/04 , C07D215/54 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/12 , C07D409/14
摘要: This invention provides compounds of Formula (I), having the structure where T, Z, X, A, R1, R2a, R2b, R2c, R3, R4, and n are defined herein, or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of osteoporosis and polycystic kidney disease.
摘要翻译: 本发明提供式(I)化合物,其具有其中T,Z,X,A,R 1,R 2a,R 2b,R 2c,R 3,R 4, 和n在本文中定义,或其药学上可接受的盐,其可用作抗肿瘤剂并用于治疗骨质疏松症和多囊肾病。
-
4.3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors 失效
标题翻译: 3-氰基喹啉,3-氰基-1,6-萘啶和3-氰基-1,7-萘啶作为蛋白激酶抑制剂公开(公告)号:US06521618B2
公开(公告)日:2003-02-18
申请号:US09820070
申请日:2001-03-28
申请人: Diane Harris Boschelli , Yanong Wang , Frank Charles Boschelli , Dan Maarten Berger , Nan Zhang , Dennis William Powell , Fei Ye , Ayako Yamashita , Frenel Fils DeMorin , Biqi Wu , Hwei-Ru Tsou , Elsebe Geraldine Overbeek-Klumpers , Allan Wissner
发明人: Diane Harris Boschelli , Yanong Wang , Frank Charles Boschelli , Dan Maarten Berger , Nan Zhang , Dennis William Powell , Fei Ye , Ayako Yamashita , Frenel Fils DeMorin , Biqi Wu , Hwei-Ru Tsou , Elsebe Geraldine Overbeek-Klumpers , Allan Wissner
IPC分类号: A61K315377
CPC分类号: C07D401/04 , C07D215/54 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/12 , C07D409/14
摘要: This invention provides compounds of Formula (I), having the structure where T, Z, X, A, R1, R2a, R2b, R2c, R3, R4, and n are defined herein, or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of osteoporosis and polycystic kidney disease.
摘要翻译: 本发明提供具有其中T,Z,X,A,R 1,R 2a,R 2b,R 2c,R 3,R 4和n如本文所定义的结构的式(I)化合物或其药学上可接受的盐,其可用作抗肿瘤剂 药物和治疗骨质疏松症和多囊肾病。
-
公开(公告)号:US20060247217A1
公开(公告)日:2006-11-02
申请号:US11478121
申请日:2006-06-29
申请人: Dan Berger , Minu Dutia , Frenel DeMorin , Diane Boschelli , Dennis Powell , Hwei-Ru Tsou , Allan Wissner , Nan Zhang , Fei Ye , Biqi Wu
发明人: Dan Berger , Minu Dutia , Frenel DeMorin , Diane Boschelli , Dennis Powell , Hwei-Ru Tsou , Allan Wissner , Nan Zhang , Fei Ye , Biqi Wu
IPC分类号: A61K31/496 , A61K31/655 , A61K31/4745 , A61K31/473 , C07D498/02 , C07D491/02
CPC分类号: C07D401/12 , C07D215/48 , C07D215/54 , C07D215/56 , C07D219/04 , C07D219/06 , C07D219/08 , C07D221/08 , C07D333/66 , C07D333/70 , C07D401/14 , C07D471/04 , C07D491/04 , C07D495/04 , C07D513/04 , C07F7/0812
摘要: This invention provides compounds of formula 1, having the structure which are useful as inhibitors of protein tyrosine kinase and are antiproliferative agents.
-
6.3-SUBSTITUTED-1H-INDOLE, 3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 审中-公开
标题翻译: 3-取代的1H-吲哚,3-取代的1H-吡咯并[2,3-b]吡啶和3-取代的1H-吡咯[3,2-B]吡啶化合物,它们作为MTOR激酶和PI3激酶抑制剂 ,和他们的合成公开(公告)号:US20100061982A1
公开(公告)日:2010-03-11
申请号:US12556833
申请日:2009-09-10
申请人: Semiramis Ayral-Kaloustian , Tarek Suhayl Mansour , Hwei-Ru Tsou , Nan Zhang , Aranapakam Mudumbai Venkatesan , Li Di , Edward Harvel Kerns
发明人: Semiramis Ayral-Kaloustian , Tarek Suhayl Mansour , Hwei-Ru Tsou , Nan Zhang , Aranapakam Mudumbai Venkatesan , Li Di , Edward Harvel Kerns
IPC分类号: A61K39/395 , C07D405/06 , A61K31/40 , C07D403/06 , A61K31/497 , C07D498/02 , A61K31/5386
CPC分类号: C07D407/06 , C07D471/04
摘要: The invention relates to 3-substituted-1H-indole, 3-substituted-1H-pyrrolo[2,3-b]pyridine, and 3-substituted-1H-pyrrolo[3,2-b]pyridine compounds of the Formula 1: or a pharmaceutically acceptable salt thereof, wherein the constituent variables are as defined herein, compositions comprising the compounds, and methods for making and using the compounds.
摘要翻译: 本发明涉及式1的3-取代-1H-吲哚,3-取代-1H-吡咯并[2,3-b]吡啶和3-取代-1H-吡咯并[3,2-b]吡啶化合物: 或其药学上可接受的盐,其中组成变量如本文所定义,包含该化合物的组合物,以及制备和使用该化合物的方法。
-
7.3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 审中-公开
标题翻译: 3-取代的1H-吡咯并[2,3-b]吡啶和3-取代的1H-吡咯[3,2-B]吡啶化合物,它们作为MTOR激酶和PI3激酶抑制剂使用,以及它们的合成公开(公告)号:US20090298820A1
公开(公告)日:2009-12-03
申请号:US12473658
申请日:2009-05-28
申请人: Hwei-Ru Tsou , Gary Harold Birnberg , Gloria Jean MacEwan , Semiramis Ayral-Kaloustian , Matthew Gregory Bursavich , Sabrina Lombardi , Nan Zhang , Adam Matthew Gilbert , George Theordore Grosu , Natasja Brooijmans , Thai Hiep Nguyen
发明人: Hwei-Ru Tsou , Gary Harold Birnberg , Gloria Jean MacEwan , Semiramis Ayral-Kaloustian , Matthew Gregory Bursavich , Sabrina Lombardi , Nan Zhang , Adam Matthew Gilbert , George Theordore Grosu , Natasja Brooijmans , Thai Hiep Nguyen
IPC分类号: A61K31/437 , A61K31/5375 , A61K31/5377 , A61K31/496 , C07D471/04 , A61P35/00 , C07D498/08 , A61P29/00 , A61P17/00 , A61P19/00
CPC分类号: C07D471/04 , C07D498/08
摘要: The invention relates to 3-substituted-1H-pyrrolo[2,3-b]pyridine, and 3-substituted-1H-pyrrolo[3,2-b]pyridine compounds of the Formula 1: or a pharmaceutically acceptable salt thereof, wherein the constituent variables are as defined herein, compositions comprising the compounds, and methods for making and using the compounds.
摘要翻译: 本发明涉及式1的3-取代-1H-吡咯并[2,3-b]吡啶和3-取代-1H-吡咯并[3,2-b]吡啶化合物或其药学上可接受的盐,其中 组成变量如本文所定义,包含该化合物的组合物,以及制备和使用该化合物的方法。
-
8.3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 审中-公开
标题翻译: 3-取代的1H-吲哚化合物,它们作为MTOR激酶和PI3激酶抑制剂使用,以及它们的合成公开(公告)号:US20090311217A1
公开(公告)日:2009-12-17
申请号:US12473605
申请日:2009-05-28
申请人: Matthew Gregory Bursavich , Nan Zhang , Semiramis Ayral-Kaloustian , James Thomas Anderson , Thai Hiep Nguyen , Sabrina Lombardi , David Malwitz , Natasja Brooijmans , Derek Cecil Cole , Adam Matthew Gilbert , Pawel Wojciech Nowak , Kaapjoo Park , Sasmita Das , Hwei-Ru Tsou , Aranapakam Mudumbai Venkatesan , Mercy Adufa Otteng , Gary Harold Birnberg , Gloria Jean MacEwan
发明人: Matthew Gregory Bursavich , Nan Zhang , Semiramis Ayral-Kaloustian , James Thomas Anderson , Thai Hiep Nguyen , Sabrina Lombardi , David Malwitz , Natasja Brooijmans , Derek Cecil Cole , Adam Matthew Gilbert , Pawel Wojciech Nowak , Kaapjoo Park , Sasmita Das , Hwei-Ru Tsou , Aranapakam Mudumbai Venkatesan , Mercy Adufa Otteng , Gary Harold Birnberg , Gloria Jean MacEwan
IPC分类号: A61K31/404 , C07D405/02 , C07D403/14 , C07D413/02 , A61K31/496 , A61K31/5377 , A61K38/21 , A61K39/395 , A61P35/00
CPC分类号: C07D405/14 , C07D405/06
摘要: The invention relates to 3-substituted-1H-indole compounds of the Formula I: or a pharmaceutically acceptable salt thereof, wherein the constituent variables are as defined herein, compositions comprising the compounds, and methods for making and using the compounds.
摘要翻译: 本发明涉及式I的3-取代-1H-吲哚化合物或其药学上可接受的盐,其中组分变量如本文所定义,包含该化合物的组合物,以及制备和使用该化合物的方法。
-
公开(公告)号:US06638929B2
公开(公告)日:2003-10-28
申请号:US09751274
申请日:2000-12-29
申请人: Dan M. Berger , Minu D. Dutia , Frenel F. DeMorin , Diane H. Boschelli , Dennis W. Powell , Hwei-Ru Tsou , Allan Wissner , Nan Zhang , Fei Ye , Biqi Wu
发明人: Dan M. Berger , Minu D. Dutia , Frenel F. DeMorin , Diane H. Boschelli , Dennis W. Powell , Hwei-Ru Tsou , Allan Wissner , Nan Zhang , Fei Ye , Biqi Wu
IPC分类号: A61K31535
CPC分类号: C07D401/12 , C07D215/48 , C07D215/54 , C07D215/56 , C07D219/04 , C07D219/06 , C07D219/08 , C07D221/08 , C07D333/66 , C07D333/70 , C07D401/14 , C07D471/04 , C07D491/04 , C07D495/04 , C07D513/04 , C07F7/0812
摘要: This invention provides compounds of formula 1, having the structure which are useful as inhibitors of protein tyrosine kinase and are antiproliferative agents.
摘要翻译: 本发明提供式1化合物,其具有可用作蛋白酪氨酸激酶抑制剂的结构,并且是抗增殖剂。
-
公开(公告)号:US06288082B1
公开(公告)日:2001-09-11
申请号:US09406573
申请日:1999-09-24
申请人: Allan Wissner , Hwei-Ru Tsou , Dan M. Berger , Middleton B. Floyd, Jr. , Philip R. Hamann , Nan Zhang , Mark E. Salvati , Philip Frost
发明人: Allan Wissner , Hwei-Ru Tsou , Dan M. Berger , Middleton B. Floyd, Jr. , Philip R. Hamann , Nan Zhang , Mark E. Salvati , Philip Frost
IPC分类号: A61K3147
CPC分类号: C07D401/12 , C07D215/48 , C07D417/12
摘要: This invention provides compounds of formula I having the structure wherein G1, G2, R1, R4, Z, n, and X are defined in the specification or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of polycystic kidney disease.
-
-
-
-
-
-
-
-
-